Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Keros Therapeutics, Inc. Director's Dealing 2021

Mar 6, 2021

32602_dirs_2021-03-05_fe61fed3-6235-40f8-b22f-2bcf2fbe21b7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Keros Therapeutics, Inc. (KROS)
CIK: 0001664710
Period of Report: 2021-03-03

Reporting Person: Knowles Julius (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-03 Common Stock S 793 $55.91 Disposed 643695 Indirect
2021-03-03 Common Stock S 518 $55.91 Disposed 429765 Indirect
2021-03-03 Common Stock S 3004 $56.95 Disposed 640691 Indirect
2021-03-03 Common Stock S 1958 $56.95 Disposed 427807 Indirect
2021-03-03 Common Stock S 2903 $57.79 Disposed 637788 Indirect
2021-03-03 Common Stock S 1894 $57.79 Disposed 425913 Indirect
2021-03-03 Common Stock S 761 $58.88 Disposed 637027 Indirect
2021-03-03 Common Stock S 496 $58.88 Disposed 425417 Indirect
2021-03-04 Common Stock S 1662 $54.22 Disposed 635365 Indirect
2021-03-04 Common Stock S 1086 $54.22 Disposed 424331 Indirect
2021-03-04 Common Stock S 2962 $55.21 Disposed 632403 Indirect
2021-03-04 Common Stock S 1932 $55.21 Disposed 422399 Indirect
2021-03-04 Common Stock S 1376 $56.18 Disposed 631027 Indirect
2021-03-04 Common Stock S 895 $56.18 Disposed 421504 Indirect
2021-03-04 Common Stock S 847 $57.21 Disposed 630180 Indirect
2021-03-04 Common Stock S 553 $57.21 Disposed 420951 Indirect
2021-03-04 Common Stock S 193 $58.03 Disposed 629987 Indirect
2021-03-04 Common Stock S 126 $58.03 Disposed 420825 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.39 to
$56.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnotes (2), (5), (6), (7), (8), (9), (10), (11) and (12).

F3: The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general
partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be
deemed to share voting and investment power with respect to the shares held by PIF I.

F4: The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general
partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be
deemed to share voting and investment power with respect to the shares held by PIF II.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.41 to
$57.40 inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.42 to
$58.38 inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.46 to
$59.19 inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.76 to $54.72 inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.76 to $55.75 inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.77 to $56.75 inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.80 to $57.59 inclusive.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.86 to $58.18 inclusive.